2015 International Raising C. diff. Awareness Conference & Health EXPO
Boston, MA, USA
8:00 a.m – 5:00 p.m
Join us at our 3rd annual International Raising C. diff. Awareness Conference and Health EXPO on November 9th as world-renown Healthcare Professionals, Researchers, and Infection Preventionists come together to share the latest data pertaining to C. difficile infection (CDI) prevention, treatments, clinical trials, environmental safety products, Microbiome research, Healthcare-Associated Infections and much, much more…………
Double Tree Suites Hotel – Boston – Cambridge
400 Soldiers Field Road, Boston, MA 02134 USA
1-617-783-0090 For Hotel Accommodations * * There are rooms available for Sunday evening and being offered at a special event rate for guests of the C Diff Foundation. Please inform the DoubleTree representative at the time of creating a reservation to receive the special event room rate.
Registration Fee: $75.00
Student Fee: $50.00
Registration includes the following: Admission to all presentations, formal and informal Q&A sessions, introductions to fellow healthcare professionals, continental breakfast, a plated luncheon with a choice of main entree (chicken or beef) and beverages. access to the Health EXPO exhibits, a conference book containing sponsor information, educational DVD, and a formal conference program.
Key Speaker and Conference Chair: Professor Mark Wilcox, Professor of Medical Microbiology, Leeds Institute of Biomedical and Clinical Sciences, UK. Professor Mark Wilcox is a Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals, Professor of Medical Microbiology at the University of Leeds, and is the Lead on Clostridium difficile for the Public Health England. He has formerly been the Director of Infection Prevention, Infection Control Doctor and Clinical Director of Pathology at Leeds Teaching Hospitals.
Dr. John Bartlett, MD; Assistant Professor Medicine, UCLA/Sepulveda Veterans Admin Hospital 1972-5, Associate Professor and Professor of Medicine, Tufts University School of Medicine, Boston, 1975-80, Professor of Medicine and Chair Division of Infectious Diseases Division, Johns Hopkins University School of Medicine 1980 – 2006; Professor of Medicine, 2006 – 13; Professor of Medicine emeritus, Johns Hopkins University School of Medicine, 2013.Dominant research interests: anaerobic infections and pulmonary infections 1968 – 74; community acquired pneumonia and diagnostic methods, 1974-1980; Bowel prep for elective colon surgery; Protected bronchoscopy brush catheter-1977; Clostridium difficile 1977 – 84, HIV 1983 – 2014; bioterrorism 1999 –2004; Clostridium difficile infection, HIV/AIDS and antibiotic resistance 2006-2013 with Major current interests: Clostridium difficile infection, HIV infection, antibiotic resistance, careers in infectious diseases.
Professor Simon M. Cutting, is a bacterial geneticist with over 25 years of experience with Bacillus since graduating from Oxford University with a D. Phil in 1986. His work on Bacillus probiotics provides another area of research interests and he was the first to address the fundamental mechanisms that might enable these bacteria to promote potential health benefits. Presentation Topic: CDVAX in the prevention of C. difficile infection.”
Dr. Clifford McDonald, MD, Currently the Chief of the Prevention and Response Branch in the Division of Healthcare Quality Promotion at the Center of Disease Control (CDC). Dr. McDonald graduated from Northwestern University Medical School, completed his Internal Medicine Residency at Michigan State University, and an Infectious Disease Fellowship at the University of South Alabama, following which he completed a fellowship in Medical Microbiology at Duke University. He is the author or co-author of over 100 peer-reviewed publications with his main interests in the epidemiology and prevention of healthcare-associated infections, especially Clostridium difficile infections, and the prevention of antimicrobial resistance. Dr. McDonald’s Presentation Topic: “Clostridium difficile disinfecting and spores.”
Barley Chironda, Manager of Infection Prevention and Control (IPAC) and Medical Device Reprocessing Device at St. Joseph Health Centre in Toronto, Canada. He is certified in Infection prevention and control (CIC TM) and has worked extensively as an Infection Preventionist. Barely has been an integral to the successful decline in Clostridium difficile infections through implementing innovative technology and quality improvement behavioral changes. Barley’s presentation will show a behind the scenes account of the C. diff. management from the healthcare facilities perspective while providing a call to action.
Dr. Patricia Pietrobon, Ph.D. , Associate Vice President, Research & Development Sanofi Pasteur has over 25 years of experience in the Vaccine & Diagnostic industries and more then 20 years in leadership roles focusing on research & development of new vaccines. Patricia began her career in diagnostic assay development with a focus on validation and quality alignment to regulatory requirements and GXPs. Patricia has been with Sanofi Pasteur for over 25 years and has contributed to the development and licensure of new bacterial & viral vaccines for pediatric & adult populations worldwide.
Dr. Martha Clokie, PhD, Leicester UK, Professor in Microbiology. Dr. Cloakie’s research focuses on phages that infect bacterial pathogens of medical relevance and has published 41 papers in this area. Her major focus has been on Clostridium difficile where she has isolated a large phage collection. In vitro and in vivo data has shown that the viruses have therapeutic potential. A patent has been filed on these phages and working with AmpliPhi to develop a product. Dr. Cloakie has regular contact with the BBC and other media to talk about her work, and other phage projects, and has consulted with Science museum, London and Eden Project, UK to advise on bacteriophage displays.
Professor Nancy Sheridan, a C. diff. Survivor and Associate Professor at the Fashion Institute of Technology and a winner of the prestigious SUNY Chancellor’s Award for Excellence in Teaching. Professor Sheridan will share her personal experience being treated for a painful and extended journey with a C. diff. infection (CDI). Professor Sheridan has been teaching since fall 2000 in the Fashion Merchandising Management Department within the School of Business and Technology. For the past seven years, she has also taught at the University of Pennsylvania, Wharton Business School to undergraduate and MBA students.
Dr Mel Thomson, PhD, completed her Honors degree in microbiology and immunology at the University of Melbourne . She then immigrated to the UK where she worked on various projects as diverse as allergy and cancer before undertaking further studies. She completed a Masters of Research in functional genomics before reading for a PhD in microbial genetic regulation in Neisseria species, both at University of York, UK. After the award of her PhD, Dr Thomson became interested the host-pathogen interactions at the Leeds Institute of Molecular Medicine, UK. Dr Thomson returned to Australia in 2011 to start her own research group studying host-pathogen interactions in the GI tract, at Deakin Medical School. A passionate science communicator, she has recently become a national ‘torch bearer’ for the concept of crowd funding academic research, which a track record of three successful ‘Pozible’ crowd funding campaigns, ‘Mighty Maggots’, ‘Hips 4 Hipsters’ and ‘No more Poo Taboo’
+ many more……….
NOTE: *Presentations are not to be recorded audio or video or published without the presenters written and signed permission to do so by each attendee seeking publication of said presentations.
♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣ ♣
A suggested local travel coordinator, for your convenience
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
We would like to sincerely thank the following Corporate Sponsors for their continued support for the “RAISING C. diff. AWARENESS” conference being hosted in Boston, MA